Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med. 2013 Jun 20; 368(25):2385-94.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Disease-Free Survival
Female
Glutamates
Guanine
Humans
Kaplan-Meier Estimate
Lung Neoplasms
Male
Middle Aged
Protein Kinase Inhibitors
Pyrazoles
Pyridines
Quality of Life
Taxoids
Young Adult
authors with profiles
Alice Tsang Shaw, Ph.D., M.D.